The coordinated expression of CCL2 & CCL5 and of TNFα & IL-1β along stages of breast cancer development and progression is important because the activities of the four factors are not fully overlapping (Refs [3,5-24] for CCL2 & CCL5, [25-59] for TNFα and IL-1β). The gene discussed is CCL2; the disease is breast carcinoma.